DMAC DiaMedica Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Get AI intraday signals

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DMAC
(Try 14 days for Free)

View a ticker or compare two or three

Compare

DMAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DMAC
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

DMAC is expected to report earnings to rise 15.00% to -17 cents per share on March 25

DiaMedica Therapeutics DMAC Stock Earnings Reports

Q4'24

Est.

$-0.17

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.02

Q4'23

Beat

by $0.02

The last earnings report on November 13 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 116.29K shares outstanding, the current market capitalization sits at 206.32M.

A.I. Advisor

published General Information

General Information

a developer of novel therapeutic compounds for diabetes and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

301 Carlson Parkway

Phone

+1 763 496-5454

Employees

Web

https://www.diamedica.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

DMAC and Stocks

Correlation & Price change

A.I.dvisor tells us that DMAC and VICP have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DMAC and VICP's prices will move in lockstep.

Ticker / NAME	Correlation To DMAC	1D Price Change %
DMAC	100%	-2.07%
VICP - DMAC	33% Poorly correlated	N/A
CYYNF - DMAC	30% Poorly correlated	N/A
CSLLY - DMAC	26% Poorly correlated	+0.84%
PCVX - DMAC	26% Poorly correlated	+0.41%
STTK - DMAC	24% Poorly correlated	+5.50%
More